MEI PHARMA INC (MEIP) Stock Overview
USA - NASDAQ:MEIP - US55279B3015 - Common Stock
MEIP Key Statistics, Chart & Performance
The current stock price of MEIP is 3.07 USD. In the past month the price decreased by -35.91%. In the past year, price increased by 1.32%.
MEIP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.74 | 406.64B | ||
| AMGN | AMGEN INC | 13.49 | 158.34B | ||
| GILD | GILEAD SCIENCES INC | 14.67 | 140.93B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.78 | 103.30B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.83 | 62.06B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.25B | ||
| ARGX | ARGENX SE - ADR | 85 | 48.22B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.56 | 37.84B | ||
| INSM | INSMED INC | N/A | 33.46B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.28B | ||
| NTRA | NATERA INC | N/A | 23.38B | ||
| BIIB | BIOGEN INC | 9.62 | 22.59B |
Related stock screener links
About MEIP
Company Profile
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. The company is headquartered in San Diego, California and currently employs 28 full-time employees. The company went IPO on 2003-12-18. The firm's treasury initiative is anchored by Litecoin. The firm has discontinued the clinical development of voruciclib, while certain nonclinical activities related to its drug candidate assets continue to be conducted by it. As part of the review of strategic alternatives, the Company may consider options such as out-licensing opportunities for existing programs and merger and acquisition opportunities.
Company Info
MEI PHARMA INC
9920 Pacific Heights Blvd, Suite 150
San Diego CALIFORNIA 92130 US
CEO: Daniel P. Gold
Employees: 28
Phone: 18583697100
MEI PHARMA INC / MEIP FAQ
What is the stock price of MEI PHARMA INC today?
The current stock price of MEIP is 3.07 USD. The price increased by 10.43% in the last trading session.
What is the ticker symbol for MEI PHARMA INC stock?
The exchange symbol of MEI PHARMA INC is MEIP and it is listed on the Nasdaq exchange.
On which exchange is MEIP stock listed?
MEIP stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MEI PHARMA INC stock?
6 analysts have analysed MEIP and the average price target is 6.12 USD. This implies a price increase of 99.35% is expected in the next year compared to the current price of 3.07. Check the MEI PHARMA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MEI PHARMA INC worth?
MEI PHARMA INC (MEIP) has a market capitalization of 100.82M USD. This makes MEIP a Micro Cap stock.
How many employees does MEI PHARMA INC have?
MEI PHARMA INC (MEIP) currently has 28 employees.
What are the support and resistance levels for MEI PHARMA INC (MEIP) stock?
MEI PHARMA INC (MEIP) has a support level at 2.77 and a resistance level at 4.65. Check the full technical report for a detailed analysis of MEIP support and resistance levels.
Is MEI PHARMA INC (MEIP) expected to grow?
The Revenue of MEI PHARMA INC (MEIP) is expected to decline by -100% in the next year. Check the estimates tab for more information on the MEIP EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MEI PHARMA INC (MEIP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MEIP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MEIP, evaluating the profitability, health, valuation and growth aspects
- MEI PHARMA INC (MEIP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MEI PHARMA INC (MEIP) Sales and EPS estimates to see what analysts future expectations are.
- MEI PHARMA INC (MEIP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MEI PHARMA INC (MEIP) Insider and Institutional Ownership to learn about the owners and their transactions.
- MEI PHARMA INC (MEIP) Stock Chart to make your own analysis
- MEI PHARMA INC (MEIP) Latest news and press-releases to stay up to date.
Does MEI PHARMA INC (MEIP) stock pay dividends?
MEIP does not pay a dividend.
When does MEI PHARMA INC (MEIP) report earnings?
MEI PHARMA INC (MEIP) will report earnings on 2025-09-17, after the market close.
What is the Price/Earnings (PE) ratio of MEI PHARMA INC (MEIP)?
The PE ratio for MEI PHARMA INC (MEIP) is 1.15. This is based on the reported non-GAAP earnings per share of 2.67 and the current share price of 3.07 USD. Check the full fundamental report for a full analysis of the valuation metrics for MEIP.
MEIP Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to MEIP. When comparing the yearly performance of all stocks, MEIP is one of the better performing stocks in the market, outperforming 75.49% of all stocks.
MEIP Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MEIP. No worries on liquidiy or solvency for MEIP as it has an excellent financial health rating, but there are worries on the profitability.
MEIP Financial Highlights
Over the last trailing twelve months MEIP reported a non-GAAP Earnings per Share(EPS) of 2.67. The EPS increased by 157.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -152.38% | ||
| ROE | -162.03% | ||
| Debt/Equity | 0 |
MEIP Forecast & Estimates
6 analysts have analysed MEIP and the average price target is 6.12 USD. This implies a price increase of 99.35% is expected in the next year compared to the current price of 3.07.
For the next year, analysts expect an EPS growth of -339.91% and a revenue growth -100% for MEIP